Pricing

Log inSign up

Shinobi Therapeutics

8 people · 0 jobs
‌

Shinobi Therapeutics is developing a new class of hypoimmune CD8ab iPS-T cells for cancer and beyond by using immune evasion to unlock the full potential of iPSCs.

Industries

Biotechnology, Life Sciences

Headquarters

South San Francisco, United States

Employees

11-50

Links

Org chart

Dan Kemp
Chief Executive Officer
Collapse
Bhanu Iyer
VP US Operations & HR
RG
Ryosuke Gonotsubo
Chief Of Staff
Tobias Deuse
Co-founder
Molly Cole
Head Of BD And R&d Strategy

Teams

This company has no teams yet

Offices

Similar companies

Tango Therapeutics

3 followers

Science

6 followers

Cellares

4 followers

Amgen

280 followers

Revvity

9 followers

Gilead Sciences

159 followers

Regeneron

130 followers

Illumina

79 followers

Agilent Technologies

81 followers

Verily Life Sciences

45 followers

Alexion Pharmaceuticals

44 followers

Explore companies